Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Alere Inc    ALR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2012 | 09:20pm CET

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALERE INC
12/10 ALERE INC : Lundin Law PC Announces Securities Class Action Lawsuit against Aler..
12/10 ALERE INVESTIGATION INITIATED BY FOR :  Kahn Swick & Foti, LLC Investigates Aler..
12/09 ALERE INC : Khang & Khang LLP Announces Securities Class Action Lawsuit against ..
12/09 ALERE NOTICE : Rosen Law Firm Reminds Alere Inc. Investors of Important Deadline..
12/08 ALERE : The Law Offices of Howard G. Smith Announces the Filing of a Securities ..
12/08 ALERE : Abbott Files Lawsuit To Terminate Its Proposed Acquisition Of Alere
12/08 ALERE : Abbott sues to get out of Alere deal
12/07 ALERE : Abbott wants to get out of $5.8 billion Alere deal
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07 ALERE INC : Lundin Law PC Announces Securities Class Action Lawsuit against Aler..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08 AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06:14a Abbott - Revenue Trends Largely Explain Lower 2018 Estimate
12/08 Abbott Vs. Alere, Or Kramer Vs. Kramer
12/07 Alere takes issue with Abbott on its plan to walk away
12/07 Alere Presents A Potential Holiday Sale Opportunity For Merger Arbitrage Inve..
12/07 Abbott to back out of Alere deal